For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251201:nRSA7094Ja&default-theme=true
RNS Number : 7094J Polar Capital Global Health Tst PLC 01 December 2025
POLAR CAPITAL GLOBAL HEALTHCARE TRUST PLC ("the Company")
Legal Entity Identifier: 549300YV7J2TWLE7PV84
1 December 2025
Continuing Shareholders - Net Asset Value
As at the close of business on 28 November 2025 the Company's unaudited net
asset value per ordinary share, calculated in accordance with the guidelines
of the Association of Investment Companies, was 427.62p (cum income). For the
avoidance of doubt, this net asset value per ordinary share has been
calculated on the basis of total voting rights of 94,016,974, being the
estimated issued share capital (excluding shares held in treasury) following
completion of the Tender Offer.
Tendering Shareholders - Tender Price
As announced earlier on 1 December 2025, the Tender Price per ordinary share
tendered is 425.61p, being equal to the prevailing net asset value per
ordinary share as at the close of business on 27 November 2025 less the Tender
Offer Expenses per share.
In accordance with the terms of the Tender Offer, 27,253,026 ordinary shares
will be purchased by Panmure Liberum Limited on or around 2 December 2025 and
all such shares will then be repurchased by the Company pursuant to the
Repurchase Agreement, and placed into treasury.
Capitalised terms used, but not defined, in this announcement have the same
meaning as given in the Circular dated 22 October 2025.
- ENDS -
For further information, please call:
Elona Gega (Investment Trust Operations Department)
Tracey Lago/Jumoke Kupoluyi (Polar Capital Secretarial Services)
Polar Capital Partners Limited
Tel: 020 7227 2700
http://www.polarcapitalglobalhealthcaretrust.co.uk
(http://www.polarcapitalglobalhealthcaretrust.co.uk/)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NAVUPGPAPUPAGGG
Copyright 2019 Regulatory News Service, all rights reserved
Recent news on Polar Capital Global Healthcare Trust